Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jayashree Kalpathy-Cramer

Concepts (402)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Retinopathy of Prematurity
35
2026
161
6.390
Why?
Artificial Intelligence
38
2025
334
5.430
Why?
Image Processing, Computer-Assisted
24
2026
772
4.540
Why?
Glioblastoma
15
2024
347
3.090
Why?
Brain Neoplasms
23
2024
1304
3.050
Why?
Machine Learning
23
2026
553
2.920
Why?
Algorithms
38
2024
1763
2.430
Why?
Uterine Cervical Neoplasms
8
2025
287
2.380
Why?
Diagnostic Imaging
19
2024
326
2.200
Why?
Radiology
10
2024
170
1.930
Why?
Natural Language Processing
7
2023
99
1.870
Why?
Magnetic Resonance Imaging
41
2024
3709
1.840
Why?
Information Storage and Retrieval
8
2015
120
1.720
Why?
Retina
7
2026
314
1.570
Why?
Neuroimaging
7
2022
272
1.530
Why?
Glioma
8
2022
427
1.420
Why?
Cervix Uteri
3
2025
53
1.370
Why?
Radiotherapy Planning, Computer-Assisted
5
2016
142
1.280
Why?
Image Interpretation, Computer-Assisted
13
2025
278
1.210
Why?
ROC Curve
16
2026
586
1.070
Why?
Software
10
2024
676
1.070
Why?
Papillomavirus Infections
5
2025
380
1.070
Why?
Humans
162
2026
141187
1.040
Why?
Colposcopy
2
2025
22
1.010
Why?
Optic Disk
2
2025
52
0.980
Why?
Optical Imaging
1
2026
66
0.920
Why?
Glaucoma
2
2025
241
0.900
Why?
Tomography, X-Ray Computed
15
2023
2746
0.880
Why?
Fundus Oculi
6
2026
86
0.880
Why?
Geographic Atrophy
1
2026
91
0.880
Why?
Severity of Illness Index
9
2024
2892
0.870
Why?
Telemedicine
7
2023
891
0.860
Why?
Gestational Age
18
2026
957
0.850
Why?
Tomography, Optical Coherence
2
2025
257
0.840
Why?
Reproducibility of Results
28
2025
3348
0.830
Why?
Infant, Newborn
35
2026
6275
0.820
Why?
Radiology Information Systems
4
2022
31
0.790
Why?
Solitary Pulmonary Nodule
3
2021
21
0.790
Why?
Privacy
1
2023
42
0.780
Why?
Ophthalmology
5
2023
105
0.780
Why?
Breast Neoplasms
7
2024
2250
0.770
Why?
Diagnostic Techniques, Ophthalmological
3
2018
50
0.760
Why?
Ophthalmoscopy
8
2024
38
0.710
Why?
Radiologists
4
2024
52
0.710
Why?
Bronchopulmonary Dysplasia
1
2026
395
0.670
Why?
Sensitivity and Specificity
14
2024
1973
0.660
Why?
Crowdsourcing
1
2020
18
0.660
Why?
Medicine
1
2021
125
0.630
Why?
Retinal Vessels
6
2024
75
0.620
Why?
Retrospective Studies
27
2026
16273
0.610
Why?
Breast Density
3
2024
7
0.610
Why?
Mammography
4
2024
159
0.590
Why?
Stroke
3
2023
1154
0.580
Why?
Retinal Vein
4
2021
13
0.550
Why?
Isocitrate Dehydrogenase
1
2017
72
0.530
Why?
Female
58
2026
75515
0.520
Why?
Receptors, Vascular Endothelial Growth Factor
1
2016
109
0.500
Why?
Lung Neoplasms
5
2021
2560
0.490
Why?
Tumor Burden
4
2023
312
0.490
Why?
Phenylurea Compounds
1
2016
95
0.490
Why?
Databases, Factual
8
2021
1444
0.470
Why?
Quinolines
1
2016
160
0.470
Why?
Gallbladder Neoplasms
3
2011
19
0.470
Why?
Peripheral Arterial Disease
4
2023
490
0.460
Why?
Radiography, Thoracic
5
2022
178
0.450
Why?
Prostatic Neoplasms
5
2024
1048
0.450
Why?
Pattern Recognition, Automated
5
2023
74
0.450
Why?
Neonatal Screening
5
2026
172
0.450
Why?
Benchmarking
6
2024
188
0.440
Why?
Infant, Premature
10
2026
597
0.440
Why?
Hypertension, Pulmonary
1
2026
1936
0.430
Why?
Uterine Cervical Dysplasia
2
2025
45
0.430
Why?
Delivery of Health Care
1
2021
961
0.430
Why?
Subtraction Technique
1
2014
25
0.430
Why?
Early Detection of Cancer
5
2025
441
0.420
Why?
Radiation Oncology
2
2014
86
0.420
Why?
Neoplasm Recurrence, Local
2
2019
1073
0.420
Why?
Retinal Artery
3
2021
17
0.420
Why?
Chemoradiotherapy
6
2018
232
0.420
Why?
Male
52
2026
69783
0.420
Why?
Photography
6
2021
115
0.420
Why?
Vocabulary, Controlled
1
2014
47
0.420
Why?
White Matter
3
2023
147
0.410
Why?
Phantoms, Imaging
7
2023
150
0.400
Why?
Multimodal Imaging
1
2014
120
0.400
Why?
Datasets as Topic
5
2021
125
0.380
Why?
Survival Analysis
4
2016
1319
0.370
Why?
Middle Aged
31
2025
34434
0.360
Why?
Aged
29
2025
24574
0.360
Why?
Cerebral Blood Volume
3
2020
5
0.360
Why?
Contrast Media
9
2020
470
0.350
Why?
Radiotherapy, Conformal
1
2011
73
0.350
Why?
Internet
2
2014
690
0.350
Why?
Mass Screening
4
2025
1310
0.350
Why?
Adrenoleukodystrophy
2
2023
9
0.340
Why?
Clinical Competence
2
2016
1202
0.340
Why?
Proportional Hazards Models
4
2011
1261
0.330
Why?
Brain
8
2021
2858
0.330
Why?
Radiographic Image Interpretation, Computer-Assisted
2
2023
118
0.320
Why?
Precision Medicine
3
2024
434
0.320
Why?
Medical Informatics
4
2020
101
0.310
Why?
Head and Neck Neoplasms
5
2020
553
0.310
Why?
Neoplasms
7
2024
2741
0.300
Why?
Database Management Systems
1
2008
51
0.290
Why?
User-Computer Interface
4
2015
164
0.280
Why?
Radiotherapy, Adjuvant
1
2008
219
0.280
Why?
Endovascular Procedures
2
2023
355
0.280
Why?
Automation
5
2020
100
0.270
Why?
Observer Variation
4
2024
355
0.270
Why?
Infant
12
2026
9818
0.260
Why?
Lung
6
2022
4134
0.260
Why?
Prognosis
9
2024
4073
0.260
Why?
Adult
26
2025
39177
0.250
Why?
Radiography
5
2022
844
0.240
Why?
Risk Factors
9
2026
10438
0.230
Why?
Diffusion Magnetic Resonance Imaging
2
2018
155
0.230
Why?
Endoscopy, Gastrointestinal
1
2007
232
0.230
Why?
Predictive Value of Tests
5
2025
2070
0.230
Why?
Uncertainty
1
2026
138
0.230
Why?
Antineoplastic Agents
1
2016
2166
0.230
Why?
Rectal Neoplasms
2
2021
152
0.230
Why?
Oropharyngeal Neoplasms
2
2015
54
0.230
Why?
Reference Standards
7
2021
186
0.220
Why?
Neoplasm Grading
3
2024
316
0.210
Why?
Adenocarcinoma in Situ
1
2023
1
0.210
Why?
Forecasting
3
2019
384
0.210
Why?
Statistics as Topic
2
2014
302
0.200
Why?
Postoperative Care
2
2019
279
0.200
Why?
Ranibizumab
1
2023
21
0.200
Why?
Imaging, Three-Dimensional
4
2023
567
0.200
Why?
Radiotherapy, Intensity-Modulated
4
2016
137
0.190
Why?
Neovascularization, Pathologic
3
2024
296
0.190
Why?
Diagnosis, Computer-Assisted
2
2021
90
0.190
Why?
Biomedical Research
3
2024
703
0.190
Why?
Long QT Syndrome
1
2023
70
0.190
Why?
Documentation
2
2015
199
0.190
Why?
Macular Degeneration
1
2024
186
0.190
Why?
Oxygen
2
2021
993
0.190
Why?
Computer Communication Networks
2
2020
33
0.180
Why?
Quality Assurance, Health Care
2
2014
331
0.180
Why?
Rheumatic Diseases
1
2022
92
0.180
Why?
Diverticulitis
1
2021
8
0.180
Why?
Patient-Specific Modeling
2
2024
42
0.180
Why?
Biomarkers
4
2018
4174
0.170
Why?
Cohort Studies
6
2022
5799
0.170
Why?
Hospital Units
1
2021
32
0.170
Why?
Racism
1
2023
139
0.170
Why?
Musculoskeletal System
1
2021
49
0.170
Why?
Intestinal Obstruction
1
2021
52
0.170
Why?
India
1
2021
208
0.170
Why?
Dacarbazine
3
2015
98
0.170
Why?
Tibial Meniscus Injuries
1
2021
49
0.170
Why?
Perfusion Imaging
1
2020
62
0.160
Why?
Microcirculation
2
2017
150
0.160
Why?
Radiometry
1
2020
54
0.160
Why?
Hyperemia
1
2020
49
0.160
Why?
Biomarkers, Tumor
3
2016
1251
0.160
Why?
Health Information Exchange
1
2020
24
0.160
Why?
Medical Records Systems, Computerized
2
2013
96
0.160
Why?
Carcinoma, Squamous Cell
2
2015
642
0.160
Why?
Brain Ischemia
1
2023
349
0.160
Why?
Signal Processing, Computer-Assisted
2
2017
151
0.160
Why?
Brain Diseases
1
2021
149
0.160
Why?
Area Under Curve
4
2021
324
0.160
Why?
Cerebellar Neoplasms
1
2022
179
0.160
Why?
Lung Injury
1
2022
227
0.160
Why?
Positron Emission Tomography Computed Tomography
1
2020
109
0.150
Why?
Low Back Pain
1
2021
108
0.150
Why?
Vascular Endothelial Growth Factor A
2
2023
550
0.150
Why?
Appendicitis
1
2021
139
0.150
Why?
Hematopoietic Stem Cell Transplantation
2
2023
668
0.150
Why?
Medulloblastoma
1
2022
218
0.150
Why?
Antineoplastic Agents, Alkylating
2
2018
71
0.150
Why?
Aneurysm, Ruptured
1
2019
35
0.150
Why?
Capillary Permeability
1
2019
149
0.150
Why?
Age Determination by Skeleton
1
2018
15
0.150
Why?
Blood-Brain Barrier
2
2017
144
0.150
Why?
Drug Resistance, Neoplasm
1
2024
830
0.150
Why?
Models, Biological
4
2024
1828
0.150
Why?
Cone-Beam Computed Tomography
1
2018
31
0.140
Why?
Colonic Neoplasms
1
2021
246
0.140
Why?
Linear Models
1
2021
857
0.140
Why?
Intracranial Aneurysm
1
2019
98
0.140
Why?
Arteries
2
2019
263
0.140
Why?
Antibodies, Monoclonal, Humanized
1
2024
852
0.140
Why?
Ventricular Dysfunction, Right
1
2021
243
0.140
Why?
Medical Record Linkage
1
2018
68
0.140
Why?
Global Health
1
2021
386
0.140
Why?
Prospective Studies
7
2023
7739
0.130
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2019
1787
0.130
Why?
Gadolinium
1
2017
81
0.130
Why?
Polysaccharides, Bacterial
1
2017
70
0.130
Why?
Bayes Theorem
2
2016
417
0.130
Why?
Diagnosis, Differential
3
2019
1498
0.130
Why?
Preoperative Period
1
2017
142
0.130
Why?
Treatment Outcome
7
2023
11120
0.130
Why?
Respiratory Insufficiency
1
2021
326
0.130
Why?
Gray Matter
1
2018
85
0.130
Why?
Patient Readmission
1
2022
706
0.130
Why?
North America
3
2024
306
0.130
Why?
Skin Diseases, Genetic
1
2016
13
0.130
Why?
Computer Simulation
5
2024
1015
0.130
Why?
Chronic Pain
1
2021
280
0.120
Why?
Pharyngeal Muscles
1
2016
5
0.120
Why?
Blood Vessels
1
2017
180
0.120
Why?
Nasopharyngeal Neoplasms
1
2016
20
0.120
Why?
SEER Program
3
2011
220
0.120
Why?
Angiogenesis Inhibitors
2
2016
230
0.120
Why?
National Cancer Institute (U.S.)
3
2020
48
0.120
Why?
Blood Volume Determination
1
2015
5
0.120
Why?
Risk Assessment
4
2025
3490
0.120
Why?
Vascular Malformations
1
2016
51
0.120
Why?
Liver Cirrhosis
1
2017
282
0.120
Why?
Acute Kidney Injury
1
2023
819
0.120
Why?
Positron-Emission Tomography
4
2021
310
0.110
Why?
Fibrosis
1
2017
541
0.110
Why?
Cranial Irradiation
1
2015
85
0.110
Why?
Physical Phenomena
1
2014
13
0.110
Why?
Organs at Risk
1
2014
35
0.110
Why?
Societies, Medical
3
2024
855
0.110
Why?
Radiation Injuries
1
2016
149
0.110
Why?
Aged, 80 and over
5
2018
7856
0.110
Why?
Longitudinal Studies
2
2019
2902
0.110
Why?
Birth Weight
3
2023
515
0.110
Why?
Brachial Plexus
1
2014
33
0.110
Why?
Tumor Microenvironment
1
2018
692
0.110
Why?
Administration, Oral
1
2016
803
0.110
Why?
Chemoradiotherapy, Adjuvant
2
2011
44
0.110
Why?
Deglutition Disorders
1
2016
148
0.110
Why?
Joint Instability
1
2016
168
0.110
Why?
Mutation
3
2024
4013
0.100
Why?
Computer-Assisted Instruction
1
2014
68
0.100
Why?
Arteriovenous Malformations
1
2013
29
0.100
Why?
Computer Literacy
1
2013
5
0.100
Why?
Bias
3
2024
229
0.100
Why?
Health Information Systems
1
2013
17
0.100
Why?
Young Adult
7
2018
13673
0.100
Why?
Survival Rate
3
2018
1970
0.090
Why?
Terminology as Topic
1
2014
244
0.090
Why?
Otorhinolaryngologic Neoplasms
1
2011
2
0.090
Why?
Nomograms
1
2011
58
0.090
Why?
Feasibility Studies
2
2014
1018
0.090
Why?
Workload
1
2013
166
0.090
Why?
Research Design
2
2014
1143
0.080
Why?
Child
8
2024
22308
0.080
Why?
Support Vector Machine
2
2021
38
0.080
Why?
Muscle, Skeletal
1
2020
1752
0.080
Why?
Emergency Service, Hospital
1
2021
2172
0.080
Why?
Liver
1
2017
1819
0.080
Why?
Periodicals as Topic
1
2012
217
0.080
Why?
Papillomaviridae
2
2023
133
0.070
Why?
Oregon
1
2008
78
0.070
Why?
Exercise
1
2020
2103
0.070
Why?
United States
5
2024
15220
0.070
Why?
Total Quality Management
1
2008
61
0.070
Why?
Lower Extremity
2
2023
439
0.070
Why?
MEDLINE
1
2008
23
0.070
Why?
Dilatation, Pathologic
2
2018
60
0.070
Why?
Follow-Up Studies
3
2024
5200
0.070
Why?
Breast
2
2019
158
0.070
Why?
Protein Kinase Inhibitors
1
2013
914
0.070
Why?
Electronic Health Records
1
2015
1122
0.060
Why?
Monte Carlo Method
2
2017
150
0.060
Why?
Cluster Analysis
1
2007
521
0.060
Why?
Clinical Protocols
2
2019
273
0.060
Why?
Tanzania
1
2025
59
0.060
Why?
Vaginal Smears
1
2025
61
0.060
Why?
Proof of Concept Study
1
2024
85
0.050
Why?
Critical Illness
2
2021
837
0.050
Why?
Netherlands
1
2024
87
0.050
Why?
Intensive Care Units, Neonatal
2
2018
268
0.050
Why?
Kinetics
2
2019
1652
0.050
Why?
Physicians
1
2013
934
0.050
Why?
Brain Infarction
1
2023
23
0.050
Why?
DNA, Viral
1
2025
366
0.050
Why?
Troponin T
1
2023
66
0.050
Why?
Models, Theoretical
2
2021
585
0.050
Why?
X-Rays
1
2022
31
0.050
Why?
DNA Helicases
1
2024
140
0.050
Why?
Data Curation
1
2022
19
0.050
Why?
Smartphone
1
2023
91
0.050
Why?
Adrenal Glands
1
2022
80
0.050
Why?
Quinazolines
2
2013
250
0.050
Why?
Logistic Models
2
2021
2086
0.050
Why?
Cross-Sectional Studies
2
2024
5636
0.050
Why?
Limb Salvage
1
2022
65
0.050
Why?
Health Services
1
2022
118
0.050
Why?
Antineoplastic Agents, Immunological
1
2024
192
0.050
Why?
Vagina
1
2024
194
0.050
Why?
Utilization Review
1
2021
41
0.040
Why?
Receptors, GABA
1
2021
14
0.040
Why?
Edema
1
2022
131
0.040
Why?
Nepal
1
2021
31
0.040
Why?
Neoadjuvant Therapy
1
2024
419
0.040
Why?
Genetic Therapy
1
2023
315
0.040
Why?
Massachusetts
1
2021
174
0.040
Why?
Case-Control Studies
2
2019
3588
0.040
Why?
Early Diagnosis
1
2021
244
0.040
Why?
Clinical Trials as Topic
2
2016
1052
0.040
Why?
Genotype
1
2025
1859
0.040
Why?
Abdomen
1
2021
136
0.040
Why?
Seizures
1
2024
442
0.040
Why?
Incidence
2
2020
2794
0.040
Why?
Internationality
1
2021
158
0.040
Why?
Cell Cycle Proteins
1
2024
624
0.040
Why?
Ankle
1
2020
61
0.040
Why?
Models, Statistical
2
2016
671
0.040
Why?
Chemotherapy, Cancer, Regional Perfusion
1
2019
29
0.040
Why?
Hematopoietic Stem Cells
1
2023
411
0.040
Why?
Disease Progression
2
2020
2793
0.040
Why?
Hand Bones
1
2018
3
0.040
Why?
Infant, Low Birth Weight
1
2020
146
0.040
Why?
Nuclear Proteins
1
2024
712
0.040
Why?
Risk
1
2021
904
0.040
Why?
Bevacizumab
1
2019
139
0.040
Why?
Quality Control
1
2019
171
0.040
Why?
Arthroscopy
1
2021
238
0.040
Why?
Genomics
1
2024
814
0.040
Why?
Radiation Exposure
1
2019
55
0.040
Why?
Reference Values
1
2020
805
0.040
Why?
Ventricular Function, Right
1
2021
283
0.040
Why?
Hyperlipidemias
1
2019
125
0.040
Why?
Medical Oncology
1
2021
316
0.040
Why?
Hemizygote
1
2017
5
0.040
Why?
Carbon Tetrachloride
1
2017
13
0.030
Why?
Diabetic Retinopathy
1
2020
200
0.030
Why?
Half-Life
1
2017
146
0.030
Why?
Diffusion
1
2017
121
0.030
Why?
Permeability
1
2017
166
0.030
Why?
Chemotherapy, Adjuvant
1
2018
378
0.030
Why?
Skull
1
2018
151
0.030
Why?
Asymptomatic Diseases
1
2017
92
0.030
Why?
Outpatients
1
2021
420
0.030
Why?
Ecosystem
1
2022
583
0.030
Why?
Consensus
1
2020
704
0.030
Why?
Tissue Distribution
1
2017
330
0.030
Why?
Signal-To-Noise Ratio
1
2016
67
0.030
Why?
Information Dissemination
1
2019
224
0.030
Why?
Expert Systems
1
2016
4
0.030
Why?
Prostate
1
2017
173
0.030
Why?
Respiration, Artificial
1
2021
683
0.030
Why?
Palate, Soft
1
2016
15
0.030
Why?
Heart Ventricles
1
2021
752
0.030
Why?
Video Recording
1
2017
190
0.030
Why?
Dose-Response Relationship, Radiation
1
2016
144
0.030
Why?
Transcription Factors
1
2024
1703
0.030
Why?
Evaluation Studies as Topic
1
2016
175
0.030
Why?
Antineoplastic Protocols
1
2015
2
0.030
Why?
Magnetic Resonance Angiography
1
2017
248
0.030
Why?
Molecular Imaging
1
2016
55
0.030
Why?
Platelet Count
1
2015
89
0.030
Why?
Perfusion
1
2016
228
0.030
Why?
Radiotherapy Dosage
1
2016
281
0.030
Why?
Motion
1
2015
100
0.030
Why?
Cerebrovascular Circulation
1
2017
271
0.030
Why?
Diffusion Tensor Imaging
1
2015
78
0.030
Why?
Disease-Free Survival
1
2016
715
0.030
Why?
Intensive Care Units
1
2021
868
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1556
0.030
Why?
Thoracic Neoplasms
1
2014
39
0.030
Why?
Mass Spectrometry
1
2017
739
0.030
Why?
Comorbidity
1
2019
1662
0.030
Why?
Image Enhancement
1
2015
191
0.030
Why?
Carcinoma
1
2016
230
0.030
Why?
DNA Modification Methylases
1
2013
17
0.030
Why?
DNA Repair Enzymes
1
2013
29
0.030
Why?
Congresses as Topic
1
2015
230
0.020
Why?
Argentina
1
2013
28
0.020
Why?
Child, Preschool
2
2018
11457
0.020
Why?
Pandemics
1
2021
1653
0.020
Why?
Molecular Targeted Therapy
1
2016
419
0.020
Why?
Statistics, Nonparametric
1
2013
434
0.020
Why?
Fluorescein Angiography
1
2013
175
0.020
Why?
Adolescent
3
2018
22007
0.020
Why?
Receptor Protein-Tyrosine Kinases
1
2013
231
0.020
Why?
Life Tables
1
2011
20
0.020
Why?
Smoking
1
2019
1601
0.020
Why?
Effect Modifier, Epidemiologic
1
2011
9
0.020
Why?
Hemodynamics
1
2016
1100
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2013
855
0.020
Why?
Tumor Suppressor Proteins
1
2013
325
0.020
Why?
Time Factors
1
2022
6956
0.020
Why?
Hospitalization
1
2021
2255
0.020
Why?
Pregnancy
1
2023
7070
0.020
Why?
Educational Status
1
2013
463
0.020
Why?
Polymerase Chain Reaction
1
2013
1056
0.020
Why?
Probability
1
2011
309
0.020
Why?
Hypertension
1
2019
1252
0.020
Why?
Diabetes Mellitus
1
2019
1074
0.020
Why?
Lymphatic Metastasis
1
2011
326
0.020
Why?
Pilot Projects
1
2015
1820
0.020
Why?
Rats
1
2017
5629
0.020
Why?
Kaplan-Meier Estimate
1
2011
908
0.020
Why?
PubMed
1
2008
11
0.020
Why?
Ultrasonography
1
2012
755
0.020
Why?
Disease Models, Animal
1
2017
4404
0.020
Why?
Neoplasm Staging
1
2011
1398
0.020
Why?
Attitude of Health Personnel
1
2013
1171
0.010
Why?
Internship and Residency
1
2014
1235
0.010
Why?
Age Factors
1
2011
3292
0.010
Why?
Mice
1
2017
18048
0.010
Why?
Animals
1
2017
37657
0.010
Why?
Kalpathy-Cramer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)